Fauzia Riaz, MD, on the Increased Use of Checkpoint Inhibitors in End-of-Life Care
MedPage Today,
The adoption of immune checkpoint inhibitors (ICIs) has led to a significant increase in the use of systemic therapy at the end…
The adoption of immune checkpoint inhibitors (ICIs) has led to a significant increase in the use of systemic therapy at the end…
1 day ago 2 Views The adoption of immune checkpoint inhibitors (ICIs) has led to a significant increase in the use of systemic…
Immunotherapy has unquestionably increased survival for some cancer patients, and in general is well tolerated.